HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The antitussive activity of delta-opioid receptor stimulation in guinea pigs.

Abstract
In this study, the activity of the delta-opioid receptor subtype-selective agonist, SB 227122, was investigated in a guinea pig model of citric acid-induced cough. Parenteral administration of selective agonists of the delta-opioid receptor (SB 227122), mu-opioid receptor (codeine and hydrocodone), and kappa-opioid receptor (BRL 52974) produced dose-related inhibition of citric acid-induced cough with ED(50) values of 7.3, 5.2, 5.1, and 5.3 mg/kg, respectively. The nonselective opioid receptor antagonist, naloxone (3 mg/kg, i.m.), attenuated the antitussive effects of codeine or SB 227122, indicating that the antitussive activity of both compounds is opioid receptor-mediated. The delta-receptor antagonist, SB 244525 (10 mg/kg, i.p.), inhibited the antitussive effect of SB 227122 (20 mg/kg, i.p.). In contrast, combined pretreatment with beta-funaltrexamine (mu-receptor antagonist; 20 mg/kg, s.c.) and norbinaltorphimine (kappa-receptor antagonist; 20 mg/kg, s.c.), at doses that inhibited the antitussive activity of mu- and kappa-receptor agonists, respectively, was without effect on the antitussive response of SB 227122 (20 mg/kg, i.p.). The sigma-receptor antagonist rimcazole (3 mg/kg, i.p.) inhibited the antitussive effect of dextromethorphan (30 mg/kg, i.p.), a sigma-receptor agonist, but not that of SB 227122. These studies provide compelling evidence that the antitussive effects of SB 227122 in this guinea pig cough model are mediated by agonist activity at the delta-opioid receptor.
AuthorsC J Kotzer, D W Hay, G Dondio, G Giardina, P Petrillo, D C Underwood
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 292 Issue 2 Pg. 803-9 (Feb 2000) ISSN: 0022-3565 [Print] United States
PMID10640321 (Publication Type: Journal Article)
Chemical References
  • Carbazoles
  • Narcotic Antagonists
  • Pyridines
  • Pyrroles
  • Pyrrolidines
  • Receptors, Opioid, delta
  • Receptors, Opioid, kappa
  • Receptors, Opioid, mu
  • SB 227122
  • BRL 52974
  • Levallorphan
  • Naloxone
  • Hydrocodone
  • Dextromethorphan
  • rimcazole
  • Codeine
Topics
  • Animals
  • CHO Cells
  • Carbazoles (pharmacology)
  • Cell Line
  • Cloning, Organism
  • Codeine (pharmacology)
  • Cough (prevention & control)
  • Cricetinae
  • Dextromethorphan (pharmacology)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Guinea Pigs
  • Humans
  • Hydrocodone (pharmacology)
  • Levallorphan (analogs & derivatives, therapeutic use)
  • Male
  • Naloxone (pharmacology)
  • Narcotic Antagonists (pharmacology)
  • Protein Binding
  • Pyridines (pharmacology)
  • Pyrroles (therapeutic use)
  • Pyrrolidines (pharmacology)
  • Receptors, Opioid, delta (agonists, drug effects, physiology)
  • Receptors, Opioid, kappa (agonists, drug effects, physiology)
  • Receptors, Opioid, mu (agonists, drug effects, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: